alendronate and Acquired Immune Deficiency Syndrome studies

alendronate and Acquired Immune Deficiency Syndrome

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

Excerpt	Relevance	Reference
" Bisphosphonates such as alendronate potently inhibit bone resorption and are effective against osteoporosis."	9.16	Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). ( Bentata, M; Costagliola, D; Darasteanu, I; Kolta, S; Lanoy, E; Missy, P; Roux, C; Rozenberg, S; Valantin, MA; Viard, JP, 2012)
" Bisphosphonates such as alendronate potently inhibit bone resorption and are effective against osteoporosis."	5.16	Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). ( Bentata, M; Costagliola, D; Darasteanu, I; Kolta, S; Lanoy, E; Missy, P; Roux, C; Rozenberg, S; Valantin, MA; Viard, JP, 2012)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Rozenberg, S	1
Lanoy, E	1
Bentata, M	1
Viard, JP	1
Valantin, MA	1
Missy, P	1
Darasteanu, I	1
Roux, C	1
Kolta, S	1
Costagliola, D	1

Studies

Rozenberg, S

Lanoy, E

Bentata, M

Viard, JP

Valantin, MA

Missy, P

Darasteanu, I

Roux, C

Kolta, S

Costagliola, D

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Efficacy of Alendronate Versus Placebo in the Treatment of HIV-1 Associated Osteoporosis, a Multicenter, Randomized, Controlled Trial. ANRS 120 Fosivir[NCT00120757]	Phase 3	140 participants	Interventional	2004-10-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Efficacy of Alendronate Versus Placebo in the Treatment of HIV-1 Associated Osteoporosis, a Multicenter, Randomized, Controlled Trial. ANRS 120 Fosivir[NCT00120757]

Phase 3

140 participants

Interventional

2004-10-31

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for alendronate and Acquired Immune Deficiency Syndrome

Article	Year
Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120). AIDS research and human retroviruses, 2012, Volume: 28, Issue:9 Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adult; Alendronate; Anti-HIV Agents; Bon	2012

Article

Year

Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

AIDS research and human retroviruses, 2012, Volume: 28, Issue:9

Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adult; Alendronate; Anti-HIV Agents; Bon

2012